Naltrexone Pill

DRUG7 trials

Conditions

Alcohol AddictionAlcohol Use DisorderAlcoholismAltitudeFibromyalgiaObsessive-Compulsive DisorderPsoriasisSleep Apnea, Central

Phase 1

Efficacy of Low Dose Naltrexone in Psoriasis

CompletedNCT04250792

Jinnah Postgraduate Medical CentrePsoriasis

Start: 2019-01-01End: 2019-09-30Updated: 2020-01-31

Phase 2

Fibromyalgia and Naltrexone: The FINAL Study

CompletedNCT04270877

Odense University HospitalFibromyalgia

Start: 2021-01-06End: 2022-12-27Updated: 2022-12-29

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

CompletedNCT05093296

Central Institute of Mental Health, MannheimAlcohol Addiction, Alcoholism, Alcohol Use Disorder

Start: 2021-12-02End: 2023-09-27Updated: 2024-03-29

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

RecruitingNCT05940324

Stanford UniversityObsessive-Compulsive Disorder

Start: 2024-02-24End: 2028-11-30Target: 150Updated: 2024-12-19

Phase 3

Emergency Department-Initiated Medications for Alcohol Use Disorder

RecruitingNCT05827159

Yale UniversityAlcohol Use Disorder

Start: 2024-08-17End: 2028-03-01Target: 240Updated: 2025-05-18

Phase 4

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

CompletedNCT05037032

VA Loma Linda Health Care SystemAltitude, Sleep Apnea, Central

Start: 2021-08-08End: 2021-10-17Updated: 2023-04-26

Bridging ED to Outpatient AUD Therapy With Naltrexone

NCT05228418

Albert Einstein Healthcare NetworkAlcohol Use Disorder

Start: 2022-03-31End: 2025-07-31Target: 20Updated: 2022-02-08

Related Papers

Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial.

2023-12-0518 citations

ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder–Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial

BMJ Open2022-04-015 citations

Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial.

2021-11-1510 citations